“If we as a health care system make insulin out of reach for people, not only is that ethically wrong, but it’s also going to cost us more in the long term.”
—Kasia Lipska ’97, ’11MHS, associate professor at the Yale School of Medicine, in a Yale News article about a study she coauthored. The study showed that 14 percent of people who use insulin in the United States spend at least 40 percent of their income, after food and housing, on the drug.